Company intelligence / Profile preview

Argenta

London, England, United Kingdomargentaglobal.com ↗

Ownership: Public · AGAG
Employees: ~1000
Development stage: Commercial

Overview

As a CRO/CDMO focused on contract services, Argenta does not have a proprietary therapeutic pipeline but supports numerous client programs from pre-clinical through commercial manufacturing stages across various animal health indications.

Therapeutic areas: OtherNeurologyInfectious Diseases
Modalities: Small moleculeBiologicDrug delivery technologies
Industry: Contract Research Organization

Partnerships

Works with most major global animal health companies as clients; specifics undisclosed but includes top ten global animal pharma companies

Financials

Market cap: $1.6B
Total revenue: $3.3B
Enterprise value: $11.2B

Beyond the preview

Go deeper on Argenta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Argenta.

Explore the full profile